Literature DB >> 33579341

Selenium levels and glutathione peroxidase activity in patients with ataxia-telangiectasia: association with oxidative stress and lipid status biomarkers.

Itana Gomes Alves Andrade1, Fabíola Isabel Suano-Souza2, Fernando Luiz Affonso Fonseca3, Carolina Sanchez Aranda Lago2, Roseli Oselka Saccardo Sarni2,4.   

Abstract

INTRODUCTION: Ataxia-Telangiectasia (A-T) is a multi-system disorder that may be associated with endocrine changes, oxidative stress in addition to inflammation. Studies suggest that selenium is a trace element related to protection against damage caused by oxidative stress.
OBJECTIVE: To describe the plasma levels of selenium and erythrocyte glutathione peroxidase activity in A-T patients and to relate them to oxidative stress and lipid status biomarkers.
METHODS: This is a cross-sectional and controlled study evaluating 22 A-T patients (age median, 12.2 years old) matched by gender and age with 18 healthy controls. We evaluated: nutritional status, food intake, plasma selenium levels, erythrocyte glutathione peroxidase activity, lipid status, inflammation and oxidative stress biomarkers.
RESULTS: Adequate levels of selenium were observed in 24/36 (66.7%) in this evaluated population. There was no statistically significant difference between the groups in selenium levels [47.6 μg/L (43.2-57.0) vs 54.6 (45.2-62.6) μg/dL, p = 0.242]. Nine of A-T patients (41%) had selenium levels below the reference value. The A-T group presented higher levels of LDL-c, non-HDL-c, oxidized LDL, Apo B, Apo-B/Apo-A-I1, LDL-c/HDL-c ratio, malondialdehyde [3.8 µg/L vs 2.8 µg/L, p = 0.029] and lower Apo-A-I1/HDL-c and glutathione peroxidase activity [7300 U/L vs 8686 U/L, p = 0.005]. Selenium levels were influenced, in both groups, independently, by the concentrations of oxidized LDL, malonaldehyde and non-HDL-c. The oxidized LDL (AUC = 0.849) and ALT (AUC = 0.854) were the variables that showed the greatest discriminatory power between groups.
CONCLUSION: In conclusion, we observed the presence of selenium below the reference value in nearly 40% and low GPx activity in A-T patients. There was a significant, inverse and independent association between selenium concentrations and oxidative stress biomarkers. Those data reinforce the importance of assessing the nutritional status of selenium in those patients.

Entities:  

Keywords:  Ataxia-telangiectasia; Cardiovascular risk; Dyslipidemia; Oxidative stress; Primary immunodeficiency; Selenium

Mesh:

Substances:

Year:  2021        PMID: 33579341      PMCID: PMC7881534          DOI: 10.1186/s13023-021-01732-5

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  43 in total

Review 1.  Importance of selenium and selenoprotein for brain function: From antioxidant protection to neuronal signalling.

Authors:  Nikolay D Solovyev
Journal:  J Inorg Biochem       Date:  2015-09-15       Impact factor: 4.155

2.  Blood metal levels and related antioxidant enzyme activities in patients with ataxia telangiectasia.

Authors:  Stefania Squadrone; Paola Brizio; Cecilia Mancini; Elisa Pozzi; Simona Cavalieri; Maria Cesarina Abete; Alfredo Brusco
Journal:  Neurobiol Dis       Date:  2015-04-13       Impact factor: 5.996

3.  [A study from Navarra. Hyperlipidemia V. What is the best definition of hyperlipemia in childhood and adolescence?].

Authors:  R Elcarte López; I Villa Elizaga; J Sada Goñi; M Gasco Eguiluz; M Oyarzábal Irigoyen; A Sola Mateos; C García Ibero; T Elcarte López; M Ferrer Giménez; A Fontaneda Estíbaliz
Journal:  An Esp Pediatr       Date:  1993-04

4.  Development of a WHO growth reference for school-aged children and adolescents.

Authors:  Mercedes de Onis; Adelheid W Onyango; Elaine Borghi; Amani Siyam; Chizuru Nishida; Jonathan Siekmann
Journal:  Bull World Health Organ       Date:  2007-09       Impact factor: 9.408

Review 5.  Lipid screening and cardiovascular health in childhood.

Authors:  Stephen R Daniels; Frank R Greer
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

6.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

Review 7.  Expanding beyond ICP-MS to better understand selenium biochemistry.

Authors:  Barbara R Cardoso; Katherine Ganio; Blaine R Roberts
Journal:  Metallomics       Date:  2019-12-11       Impact factor: 4.526

Review 8.  Selenium and its supplementation in cardiovascular disease--what do we know?

Authors:  Carina Benstoem; Andreas Goetzenich; Sandra Kraemer; Sebastian Borosch; William Manzanares; Gil Hardy; Christian Stoppe
Journal:  Nutrients       Date:  2015-04-27       Impact factor: 5.717

9.  Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients?

Authors:  Talita Lemos Paulino; Marina Neto Rafael; Sonia Hix; David Carlos Shigueoka; Sergio Aron Ajzen; Cristiane Kochi; Fabíola Isabel Suano-Souza; Rosangela da Silva; Beatriz T Costa-Carvalho; Roseli O S Sarni
Journal:  Orphanet J Rare Dis       Date:  2017-08-04       Impact factor: 4.123

Review 10.  Antioxidants and Atherosclerosis: Mechanistic Aspects.

Authors:  Khojasteh Malekmohammad; Robert D E Sewell; Mahmoud Rafieian-Kopaei
Journal:  Biomolecules       Date:  2019-07-25
View more
  3 in total

1.  Selenium-related nutritional status in patients with common variable immunodeficiency: association with oxidative stress and atherosclerosis risk.

Authors:  Itana Gomes Alves Andrade; Fabíola Isabel Suano de Souza; Fernando Luiz Affonso Fonseca; Carolina Sanchez Aranda; Roseli Oselka Saccardo Sarni
Journal:  BMC Immunol       Date:  2021-05-13       Impact factor: 3.615

2.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

Review 3.  Selenium as an important factor in various disease states - a review.

Authors:  Marek Kieliszek; Iqra Bano
Journal:  EXCLI J       Date:  2022-07-05       Impact factor: 4.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.